The comparative effectiveness of rosuvastatin vs. other statins in patients with an increased risk of failure to reach NCEP ATP III goal-Reference-Cited by-同舟云学术

The comparative effectiveness of rosuvastatin vs. other statins in patients with an increased risk of failure to reach NCEP ATP III goal

Published:2008-06-28 Issue:6 Volume:62 Page:889-895
ISSN:1368-5031
Container-title:International Journal of Clinical Practice
language:en
Short-container-title:

Author:

Harley C. R.,Gandhi S.,Heien H.,Nelson S. P.

Publisher

Hindawi Limited

Subject

General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1742-1241.2008.01771.x/fullpdf

Reference22 articles.

1. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults;Adult Treatment Panel III;JAMA,2001

2. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines;Grundy;Circulation,2004

3. Update for primary healthcare providers: recent statin trials and revised National Cholesterol Education Program III guidelines;Hennekens;Med Gen Med,2006

4. Primary prevention in high-risk dyslipidemia patients without an established cardiovascular disease: undertreatment and rationale for lipid-lowering therapy;Zafrir;Eur J Intern Med,2006

5. Clinical significance of recent lipid trials on reducing risk in patients with type 2 diabetes mellitus;Jones;Am J Cardiol,2007

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A comparison of difficulties in emotional regulations of patients with mild traumatic brain injury and normal controls;Archives of Trauma Research;2018

2. Effectiveness of rosuvastatin in reducing LDL-C and target LDL-C goal attainment in real-world clinical practice;Current Medical Research and Opinion;2009-10-05